Skip to content
IP + Technology Law
Home  »  News & Insights  »  News  »  Media Mention

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

News
Oct 2026
Knobbe Martens Partners Honored as 2027 IAM Global Leaders
IRVINE, Calif., October 23, 2026 – Knobbe Martens is pleased to share that partners Sabing Lee, Salima Merani, Ph.D., and Joseph Re have been featured in the 2027 IAM Global...
Newsletters
Nov 2026
Litigation Update | October 2026
Scientifically Impossible Claims – Not Indefinite, But Not Enabled Douglas B. Wentzel The Federal Circuit held that scientifically impossible-to-perform claims were not indefinite but were invalid for lack of enablement....
Newsletters
Nov 2026
Life Science Update | October 2026
FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors Joseph Mallon, Ph.D. & Susan M. Janicki, Ph.D. The Expedited Investigational New Drug (IND) Pilot...